We are live on ! Find out more
ALZN icon

Alzamend Neuro
ALZN

8 hedge funds and large institutions have $59.9K invested in Alzamend Neuro in 2025 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.13% less ownership

Funds ownership: 0.23% → 0.11% (-0.13%)

43% less funds holding

Funds holding: 14 → 8 (-6)

54% less capital invested

Capital invested by funds: $132K → $59.9K (-$71.8K)

86% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 7

Holders
8
Holders Change
-6
Holders Change %
-42.86%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
–
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Geode Capital Management
Geode Capital Management
Massachusetts
+$5.71K
2
Barclays
Barclays
United Kingdom
+$4.45K
3
Bank of America
Bank of America
North Carolina
+$9

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$35.5K
2
Renaissance Technologies
Renaissance Technologies
New York
-$17.4K
3
VF
Virtu Financial
New York
-$15K
4
UBS Group
UBS Group
Switzerland
-$951
5
Citigroup
Citigroup
New York
-$631
Name Holding Trade Value Shares
Change 		Change in
Stake
Geode Capital Management
1
Geode Capital Management
Massachusetts
$37.1K +$5.71K +623 +17%
Truist Financial
2
Truist Financial
North Carolina
$14.7K – – –
Barclays
3
Barclays
United Kingdom
$4.15K +$4.45K +486 New
BlackRock
4
BlackRock
New York
$3.77K – – –
Bank of America
5
Bank of America
North Carolina
$139 +$9 +1 +7%
AWM
6
Activest Wealth Management
Florida
$19 – – –
HIA
7
Harbor Investment Advisory
Maryland
$19 – – –
SS
8
SBI Securities
Japan
$17 – – –
CSB
9
City State Bank
Iowa
$4 – – –
Morgan Stanley
10
Morgan Stanley
New York
$3 – – –
PA
11
Parallel Advisors
California
$3 – – –
Citadel Advisors
12
Citadel Advisors
Florida
– -$35.5K -3,404 Closed
Renaissance Technologies
13
Renaissance Technologies
New York
– -$17.4K -1,667 Closed
VF
14
Virtu Financial
New York
– -$15K -1,413 Closed
UBS Group
15
UBS Group
Switzerland
– -$951 -91 Closed
Citigroup
16
Citigroup
New York
– -$631 -60 Closed
TRCT
17
Tower Research Capital (TRC)
New York
– -$450 -43 Closed
Osaic Holdings
18
Osaic Holdings
Arizona
– -$7 -1 Closed

ALZN Hedge Fund Activity: Q1 2025 in Review

8 of the 7,461 institutional investors tracked by Wall St. Rank reported a position in Alzamend Neuro (ALZN) for Q1 2025, worth a combined $59.9K — down 54% from $132K a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of ALZN and 1 opened new positions — a net loss of 6 holders — while 0 trimmed existing stakes and 2 added.

The largest buyer was Geode Capital Management, adding an estimated $5.71K. The largest seller was Citadel Advisors, exiting entirely with an estimated $35.5K sold.

  • 8 institutional investors held Alzamend Neuro (ALZN) as of Q1 2025, down from 14 in Q4 2024.
  • Funds reported $59.9K of Alzamend Neuro stock for Q1 2025, down 54% quarter-over-quarter.
  • 1 fund opened new Alzamend Neuro positions in Q1 2025 and 7 closed out, a net change of -6 holders.
  • The largest Alzamend Neuro buyer in Q1 2025 was Geode Capital Management, an estimated $5.71K added.
  • The largest Alzamend Neuro seller in Q1 2025 was Citadel Advisors, an estimated $35.5K sold.

Based on aggregated 13F filings for Q1 2025.